Abstract: Systems and methods for destination rating and ranking for a multiplicity of business entities in a related geographic area using a virtual scorecard.

Abstract: Disclosed herein is a tube loading system suitable for rapidly loading, handing, manipulation and storing large numbers of tubes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2??(I) (SEQ ID NO: 1), as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Disclosed herein is a tube loading system suitable for rapidly loading, handing, manipulation and storing large numbers of tubes.

Abstract: Disclosed herein is a tube loading system suitable for rapidly loading, handing, manipulation and storing large numbers of tubes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Disclosed herein is a tube loading system suitable for rapidly loading, handing, manipulation and storing large numbers of tubes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2 ??(I), as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.

Abstract: A touch sensor includes a touch pad; and a circuit configured to detect radiated energy from the touch pad. An impedance connected in series with the touch pad in the circuit, and the impedance selected to approximately match the impedance of a human finger in proximity to the touch pad. The sensor does not require floating power supplies and ground references, and does not rely upon a receiver in the circuit to detect radiated energy.

Abstract: A touch controller for a touch sensitive control system having a control interface panel and a plurality of touch detecting elements is configured to accept a first number of input signals via corresponding input connections; monitor each of said touch detecting elements individually to detect user touch activation thereof; and output signals corresponding to detected touches, wherein a number of output signals is less than a number of touch detecting elements in the interface.

Abstract: A touch sensitive control system for controlling a device includes a touch sensitive interface and a controller configured to communicate with the touch sensitive interface. The control system detects user manipulation of the touch sensitive interface with a touch detection sequence executed by the controller. The touch detection sequence determines a moving average of baseline signal level readings of the touch sensitive interface over time. The touch detection sequence compares a current baseline signal level reading to the moving average of baseline signal level readings, thereby detecting an interference event associated with an unexpectedly high current baseline signal level reading which could otherwise lead to a false touch detection.

Abstract: A control system for controlling a device includes a touch sensitive interface. The control system also includes a controller configured to communicate with the touch sensitive interface and to detect user manipulation of the touch sensitive interface with a series of non-periodic test pulses and monitored responses thereto, thereby avoiding inaccurate touch detection attributable to synchronous noise in an ambient environment of the control system.

Abstract: A touch sensitive control interface for a controlled device includes a panel defining an interface area configured to selectively input command instructions of an operator of the device. The panel has at least one primary touch portion configured to receive a true operator command, and a second touch sensor portion proximate the primary touch sensor portion configured to detect a false operator command due to a presence of a contaminant.

Abstract: The invention relates to chewing gums containing dipeptide sweetener, both in a sugar-free and in a sugar-containing form, and other chewable products. Improved flavor, in terms of both quality and persistence, in particular in the case of products which also contain flavorings based on aldehydes, is achieved when the dipeptide sweetener is a sweetening salt of an aspartic-acid-derived dipeptide sweetener and a derivative of a sweetening acid. The particle size of the sweetening salt is preferably smaller than 200 &mgr;m, and the sweetening salt is preferably present in a quantity from 100 to 6000 ppm.

Abstract: Disclosed is a method of detecting the presence of a compound of interest (such as an enzyme), or the spatial distribution within a sample of a compound of interest. The method comprises the step of impregnating or coating a suitable base material with a marker substance capable of reacting or interacting with the compound of interest, the marker substance being labeled in a detectable manner (for example fluorescently, radioactively or being colored) and having a substantially different affinity for the base material than the product of the reaction or interaction thereof with the compound of interest.